Responses to parliamentary questions
Question from Deputy Cormac Devlin - PQ 30915-26
Deputy Devlin asked about an application received by the HSE for pricing and reimbursement of baricitinib. Read the HSE response.
From: Communications and public affairs
Published: April 2026
Updated: May 2026
Documents
Question from Deputy Cormac Devlin - PQ 30915-26
PDF, 441KB, 2 pages
Summary
To ask the Minister for Health if an application has been received by the HSE for pricing and reimbursement of baricitinib for the alopecia areata indication; if not, whether the HSE or her Department has engaged with the marketing authorisation holder regarding a submission (further to a previous PQ); and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it